טוען...
A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
BACKGROUND: Autism spectrum disorder (ASD) is now understood to have multiple genetic risk genes and one example is SHANK3. SHANK3 deletions and mutations disrupt synaptic function and result in Phelan-McDermid syndrome (PMS), which causes a monogenic form of ASD with a frequency of at least 0.5% of...
שמור ב:
| הוצא לאור ב: | Mol Autism |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326443/ https://ncbi.nlm.nih.gov/pubmed/25685306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2040-2392-5-54 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|